Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheena McCormack

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Current Opinion in HIV and AIDS|November 25, 2015
The European preexposure prophylaxis revolutionGus Cairns, Sheena McCormack, Jean-Michel Molina
BMJ (Clinical Research Ed.)|December 13, 2017
Recent advances in pre-exposure prophylaxis for HIVMonica Desai, Nigel Field, Robert Grant, et al.
Lancet (London, England)|April 27, 2016
HIV moments and pre-exposure prophylaxis--Authors' replyDavid T Dunn, Mitzy Gafos, Ellen White, et al.
Sexual Health|November 30, 2018
Meet the EditorsIryna Zablotska, Jared Baeten, Nittaya Phanuphak, et al.
AIDS (London, England)|November 3, 2010
HIV prevention research: taking stock and the way forwardRichard Hayes, Saidi Kapiga, Nancy Padian, et al.
AIDS (London, England)|December 7, 2021
Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomesNicolò Girometti, Sheena McCormack, Victoria Tittle, et al.
Plos One|March 29, 2017
High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility studySibone Mocumbi, Mitzy Gafos, Khatia Munguambe, et al.
Vaccine|June 24, 2023
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trialsDavid T Dunn, Richard Gilson, Sheena McCormack, et al.
Science (New York, N.Y.)|July 2, 2011
AIDS. Turning the tide against HIVRobin J Shattock, Mitchell Warren, Sheena McCormack, et al.
BMC Medical Research Methodology|June 26, 2023
Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted eventsDavid T Dunn, Oliver T Stirrup, Sheena McCormack, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Current Opinion in HIV and AIDS|November 25, 2015
The European preexposure prophylaxis revolutionGus Cairns, Sheena McCormack, Jean-Michel Molina
BMJ (Clinical Research Ed.)|December 13, 2017
Recent advances in pre-exposure prophylaxis for HIVMonica Desai, Nigel Field, Robert Grant, et al.
Lancet (London, England)|April 27, 2016
HIV moments and pre-exposure prophylaxis--Authors' replyDavid T Dunn, Mitzy Gafos, Ellen White, et al.
Sexual Health|November 30, 2018
Meet the EditorsIryna Zablotska, Jared Baeten, Nittaya Phanuphak, et al.
AIDS (London, England)|November 3, 2010
HIV prevention research: taking stock and the way forwardRichard Hayes, Saidi Kapiga, Nancy Padian, et al.
AIDS (London, England)|December 7, 2021
Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomesNicolò Girometti, Sheena McCormack, Victoria Tittle, et al.
Plos One|March 29, 2017
High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility studySibone Mocumbi, Mitzy Gafos, Khatia Munguambe, et al.
Vaccine|June 24, 2023
Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trialsDavid T Dunn, Richard Gilson, Sheena McCormack, et al.
Science (New York, N.Y.)|July 2, 2011
AIDS. Turning the tide against HIVRobin J Shattock, Mitchell Warren, Sheena McCormack, et al.
BMC Medical Research Methodology|June 26, 2023
Interpretation of active-control randomised trials: the case for a new analytical perspective involving averted eventsDavid T Dunn, Oliver T Stirrup, Sheena McCormack, et al.
Pageof 12